Ken Delafrange is a seasoned legal and pharmaceutical professional with extensive experience in the industry. Currently serving as a Law Consultant at Guidepoint since 2021, Ken has also been a Pharmaceutical Lawyer specializing in R&D since 2012. With a solid background as a Lawyer - Scientific Counsel at The Law Offices of Peter Paul Mendel since 2003, Ken has a broad expertise that encompasses Pharmaceutical Law, Asset Protection, Trusts, and International Law. Previous roles include Pharmaceutical Business Consultant at Gerson Lehrman Group from 2003 to 2021, and Associate Director positions at Penwest Pharmaceuticals Inc. and Graham Development Inc. between 1999 and 2001. Ken began a career in pharmaceuticals as a Research Scientist at Pfizer from 1989 to 1997. Educationally, Ken holds a Doctor of Law (JD) in International Business from Bond University and a Bachelor's degree in Chemistry from the State University of New York at Plattsburgh.
This person is not in any teams
This person is not in any offices